Ziemer, a global leader in laser eye care and diagnostics dedicated to helping people see better, formed a strategic partnership with Zubisoft to offer laser nomogram and lens calculation technologies to the ophthalmic industry.
“We’re excited to work with Zubisoft to integrate IBRA's technologies into Ziemer's upcoming digital health suite (DHS) for the planning and outcome analysis of CLEAR with the Femto Z8 laser platform, and ablation treatments with the upcoming AQUARIUZ solid-state laser. Cataract treatment is another envisaged field of application” said Frank Ziemer, CEO of Ziemer.
“In doing so, our goal is to improve patient outcomes through enhanced workflow efficiency. We are convinced that our clients will benefit from vendor independent and open solutions as Zubisoft provides one.”
Zubisoft will continue to sale and develop IBRA®. As part of the partnership, Ziemer will get exclusive access to unique IBRA technology, and DHS development support.
Financial terms of the deal were not disclosed at the time of publication.
Ziemer Ophthalmic Systems AG, a Ziemer Group Company, is a privately held company incorporated in Port, Switzerland. Founded in 1998, Ziemer Group is focused on developing, manufacturing, and marketing leading edge diagnostic and surgical ophthalmic products.
Successful products developed by the group include the FEMTO LDV™ and FEMTO LDV™ Crystal Line and FEMTO LDV Z Models Femtosecond Surgical lasers, the AMADEUS® Microkeratome, the PASCAL® Dynamic Contour Tonometer and the GALILEI™ and GALILEI™ G4 and G6 Dual Scheimpflug Analyzers.